Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.148 (
Thy1
)
1,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
T cell activation is regulated by a balance between phosphorylation and dephosphorylation that is under the control of kinases and phosphatases. Here, we examined the role of a non-receptor-type protein tyrosine phosphatase,
PTP-PEST
, using retrovirus-mediated gene transduction into murine T cells. Based on observations of vector markers (GFP or
Thy1
.1), exogenous
PTP-PEST
-positive CD4(+) T cells appeared within 2 days after gene transduction; the percentage of
PTP-PEST
-positive cells tended to decrease during a resting period in the presence of IL-2 over the next 2 days. These vector markers also showed much lower expression intensities, compared with control cells, suggesting a correlation between the percent reduction and the low marker expression intensity. A catalytically inactive
PTP-PEST
mutant also showed the same tendency, and stepwise deletion mutants gradually lost their ability to induce the above phenomenon. On the other hand, these
PTP-PEST
-transduced cells did not have an apoptotic phenotype. No difference in the total cell numbers was found in the wells of a culture plate containing VEC- and
PTP-PEST
-transduced T cells. Moreover, serine/threonine kinase Akt, but not the anti-apoptotic molecules Bcl-2 and Bcl-XL, reversed the phenotype induced by
PTP-PEST
. We discuss the novel mechanism by which Akt interferes with
PTP-PEST
.
...
PMID:Effects of protein tyrosine phosphatase-PEST are reversed by Akt in T cells. 2515 68